Navigation Links
Baxter Raises Full-Year 2008 Outlook Following Strong Second-Quarter Financial Results
Date:7/17/2008

---------------------------------

TOTAL BAXTER 4% 19% 13%

==========================================================================

(1) Previously referred to as BioSurgery.

(2) Principally includes vaccines, sales of plasma to third parties,

and recombinant FIX (BeneFIX). Sales of BeneFIX ceased as of

June 30, 2007.

(3) The results of operations of the TT business were previously

reported in the BioScience business. The TT business was sold on

February 28, 2007. The TT totals above include sales of TT

products through the date of divestiture, as well as revenues

associated with manufacturing, distribution and other services

provided by the company to the buyer of the TT business post-

divestiture.


'/>"/>
SOURCE Baxter International Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

Related biology technology :

1. Bioniche Pharma Acquires Baxters ENLON(R) and ENLON-PLUS(R)
2. Baxters Board of Directors Declares Quarterly Dividend
3. Baxter Reports Solid First Quarter Financial Results and Raises Full-Year Outlook
4. Baxters V-Link Luer-Activated Device With VitalShield Protective Coating Now Available For Hospitals
5. Baxter Announces FDA Approval of ARTISS Slow-Setting Fibrin Sealant in Treatment of Burn Patients
6. Baxters Board of Directors Approves New Share Repurchase Authorization of $2 Billion
7. Baxter and Its Foundation Contribute Nearly $53 Million in 2007 to Address Critical Needs Locally and Globally
8. Baxter to Proceed With Recall of Remaining Heparin Sodium Vial Products
9. Baxter Declares Quarterly Dividend
10. Baxter Provides Update on Heparin Reactions
11. Baxters Costa Rica Facility Recognized With Shingo Prize for Excellence in Manufacturing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2014)... 14, 2014 Minerva Neurosciences (NASDAQ: ... therapies to treat neuropsychiatric diseases and disorders, today announced ... vice president of finance and chief accounting officer, effective ... senior executive with more than 20 years of experience ... science companies. His background includes the management of compliance ...
(Date:7/14/2014)... July 14, 2014 PatientCrossroads, ... platform, announced that three PatientCrossroads-based patient registries—DuchenneConnect, ... Phelan-McDermid Syndrome International Registry; and the NephCure ... awarded contracts by the Patient-Centered Outcomes Research ... of a new health data network called ...
(Date:7/13/2014)... University) -- The discovery 30 years ago of soccer-ball-shaped ... of nanotechnology research. Now, there appears to be a ... University, Shanxi University and Tsinghua University in China have ... a hollow molecular cage similar to a carbon buckyball. ... structurepreviously only a matter of speculationdoes indeed exist. , ...
(Date:7/13/2014)... (PRWEB) July 13, 2014 2014 Deep ... is a professional and in-depth study on the current ... China. , The report provides a basic overview of ... Global market analysis and Chinese domestic market analysis are ... competitive landscape of the market. A comparison between the ...
Breaking Biology Technology:Minerva Neurosciences Announces Appointment Of Frederick W. Ahlholm As VP Of Finance And Chief Accounting Officer 2PatientCrossroads Fuels Development of New National Clinical Research Network 2PatientCrossroads Fuels Development of New National Clinical Research Network 3Researchers discover boron 'buckyball' 2Researchers discover boron 'buckyball' 32014 Nano Silver Industry in Global and China Regions Development Proposals Analysis Available at DeepResearchReports.com 22014 Nano Silver Industry in Global and China Regions Development Proposals Analysis Available at DeepResearchReports.com 3
... but its repair could actually increase warming in the southern hemisphere, ... The Antarctic ozone ... but the discovery of a previously undiscovered feedback shows that it ... the past two decades. High-speed winds in the area ...
... , Jan. 25 Novavax, Inc. (Nasdaq: ... company will be presenting at the upcoming Phacilitate Vaccine Forum ... at the Grand Hyatt, Washington, D.C.  Mr. ... Alliances will be participating in a Focus Session: Fast ...
... AMSTERDAM, The Netherlands ... (Euronext: AMT), a leader in the field of,human ... the official,marketing authorisation process for its lead product ... The submission,of the Glybera(R) Marketing Authorisation Application (MAA), ...
Cached Biology Technology:Ozone hole healing could cause further climate warming 2NOVAVAX to Present at Phacilitate Vaccine Forum Washington 2010 2EMA Starts Formal Review of Glybera(R) Dossier 2EMA Starts Formal Review of Glybera(R) Dossier 3
(Date:7/11/2014)... German . ... the refraction of X-rays through a specimen instead of ... method are often of much higher quality than those ... Prof. Franz Pfeiffer are particularly interested in developing new ... X-ray phase-contrast imaging. One main goal is to make ...
(Date:7/11/2014)... researchers at the National Institute of Standards and ... their work more effectively, they often prove that ... was the case recently for M. Lorna De ... the growing specialization of glycomics. Glycomics is the ... glycans that are attached to proteins and lipids ...
(Date:7/11/2014)... China Researchers from Salk Institute for Biological Studies, ... evaluated the safety and reliability of the existing ... new method, TALEN-HDAdV, which could significantly increased gene-correction ... This study published online in Cell Stell ... stem cell-based gene therapy. , The combination of ...
Breaking Biology News(10 mins):New simple setup for X-ray phase contrast 2A new genome editing method brings the possibility of gene therapies closer to reality 2
... IOF World Congress on Osteoporosis 2008 (IOF WCO), to ... registration to benefit from special early bird rates. The ... 3-7, 2008, is the worlds largest scientific congress devoted ... to IOF Members, Non-Members and Students or Fellows, with ...
... hereditary disorder that strongly predisposes carriers to develop cancer ... Asian female, report researchers today at the American Association ... Generally, a person should have two normal copies ... the disorder known as Li-Fraumeni syndrome (LFS), one defective ...
... announced the results of a systematic effort to map ... cause of cancer deaths. Appearing in the November 4 ... provides a comprehensive view of the abnormal genetic landscape ... regions that are frequently gained or lost in human ...
Cached Biology News:Rare cancer-causing syndrome found, for the first time, in Singapore 2Genome study charts genetic landscape of lung cancer 2Genome study charts genetic landscape of lung cancer 3
... Fujifilm Life Science LAS-3000mini is a ... to chemiluminescence applications, and the perfect ... Fuiji 's LAS-3000 provides significantly improved ... , Glowell calibration standards validate that ...
Designed for use with the Agencourt CleanSEQ and Agencourt AMPure 384-well SPRI reagent kits. For use with 384-well thermal cycling plates....
... ScriptCap™ m7G Capping system ... and all of the components ... 0 on the end of ... These kits feature high efficiency ...
... Fujifilm Life Science FLA-5100 imaging system allows ... large as 40 x 46cm at a ... This system is especially suitable for protein ... array analysis for genomics., Fuji s FLA-5100 ...
Biology Products: